Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature.

Farris M, Hughes RT, Lamar Z, Soike MH, Menke JR, Ohgami RS, Winkfield K.

Clin Lymphoma Myeloma Leuk. 2018 Oct 13. pii: S2152-2650(18)31336-3. doi: 10.1016/j.clml.2018.10.004. [Epub ahead of print] Review.

PMID:
30396823
2.

An integrated flow cytometry analysis of 286 mature B cell neoplasms identifies CD13 as a useful marker for diagnostic subtyping.

Lau H, Nagy A, Atwater SK, Cascio MJ, Ohgami RS.

Int J Lab Hematol. 2018 Dec;40(6):715-720. doi: 10.1111/ijlh.12909. Epub 2018 Jul 31.

PMID:
30066366
3.

Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis.

Gars E, Purington N, Scott G, Chisholm K, Gratzinger D, Martin BA, Ohgami RS.

Haematologica. 2018 Oct;103(10):1635-1641. doi: 10.3324/haematol.2017.186627. Epub 2018 Jun 14. No abstract available.

4.

An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.

Sumarriva Lezama L, Chisholm KM, Carneal E, Nagy A, Cascio MJ, Yan J, Chang CC, Cherry A, George TI, Ohgami RS.

Histopathology. 2018 Nov;73(5):767-776. doi: 10.1111/his.13668. Epub 2018 Aug 6.

PMID:
29884995
5.

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.

Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder JL, Warnke RA, Mughal T, Ali S, Ohgami RS.

Blood Adv. 2018 Mar 13;2(5):481-491. doi: 10.1182/bloodadvances.2017009654.

6.

Mutations in the signal transducer and activator of transcription family of genes in cancer.

Shahmarvand N, Nagy A, Shahryari J, Ohgami RS.

Cancer Sci. 2018 Apr;109(4):926-933. doi: 10.1111/cas.13525. Epub 2018 Mar 2. Review.

7.

Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions.

Ohgami RS, Rosenwald A, Bagg A.

J Mol Diagn. 2018 Mar;20(2):163-165. doi: 10.1016/j.jmoldx.2018.01.002. Epub 2018 Feb 2.

PMID:
29355824
8.

A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.

Chung A, Hou Y, Ohgami RS, Von Gehr A, Fisk DG, Roskin KM, Li X, Gojenola L, Bangs CD, Arber DA, Fire AZ, Cherry AM, Zehnder JL, Gotlib J, Merker JD.

Cancer Genet. 2017 Oct;216-217:10-15. doi: 10.1016/j.cancergen.2017.05.001. Epub 2017 May 10.

PMID:
29025582
9.

Case Report: Clinical Variation in Children With Thrombopoietin Receptor (C-MPL) Mutations: Report of 2 Cases.

Lo C, Alvarez E, Ohgami RS, Jeng M.

J Pediatr Hematol Oncol. 2018 Jan;40(1):67-70. doi: 10.1097/MPH.0000000000000944.

PMID:
28859041
10.

Hematolymphoid lesions of the breast.

Hoffmann J, Ohgami RS.

Semin Diagn Pathol. 2017 Sep;34(5):462-469. doi: 10.1053/j.semdp.2017.05.007. Epub 2017 May 28. Review.

PMID:
28662998
11.

Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia.

Kunder C, Cascio MJ, Bakke A, Venkataraman G, O'Malley DP, Ohgami RS.

Am J Clin Pathol. 2017 Jun 1;147(6):596-603. doi: 10.1093/ajcp/aqx034.

PMID:
28575178
12.

A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.

Shahmarvand N, Oak JS, Cascio MJ, Alcasid M, Goodman E, Medeiros BC, Arber DA, Zehnder JL, Ohgami RS.

Int J Lab Hematol. 2017 Aug;39(4):375-383. doi: 10.1111/ijlh.12636. Epub 2017 Apr 19.

PMID:
28422420
13.
14.

The clinicopathologic significance of lymphocyte subsets in acute myeloid leukemia.

Alcasid M, Ma L, Gotlib JR, Arber DA, Ohgami RS.

Int J Lab Hematol. 2017 Apr;39(2):129-136. doi: 10.1111/ijlh.12594. Epub 2017 Jan 30.

PMID:
28133918
15.

Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations.

Oak JS, Ohgami RS.

Curr Med Res Opin. 2017 Apr;33(4):781-782. doi: 10.1080/03007995.2017.1284049. Epub 2017 Feb 3. No abstract available.

PMID:
28097878
16.
17.

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA.

Sci Transl Med. 2016 Nov 9;8(364):364ra155.

18.

Primary lymphoma of bone in the pediatric and young adult population.

Chisholm KM, Ohgami RS, Tan B, Hasserjian RP, Weinberg OK.

Hum Pathol. 2017 Feb;60:1-10. doi: 10.1016/j.humpath.2016.07.028. Epub 2016 Aug 20.

PMID:
27554207
19.

A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.

Ozawa MG, Bhaduri A, Chisholm KM, Baker SA, Ma L, Zehnder JL, Luna-Fineman S, Link MP, Merker JD, Arber DA, Ohgami RS.

Mod Pathol. 2016 Oct;29(10):1212-20. doi: 10.1038/modpathol.2016.102. Epub 2016 Jun 24.

20.

Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.

Fernandez-Pol S, Ma L, Ohgami RS, Arber DA.

Mod Pathol. 2016 Sep;29(9):996-1003. doi: 10.1038/modpathol.2016.100. Epub 2016 Jun 3.

21.

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Duncavage E, Advani RH, Agosti S, Foulis P, Gibson C, Kang L, Khoury JD, Medeiros LJ, Ohgami RS, O'Malley DP, Patel KP, Rosenbaum JN, Wilson C; Members of the Cancer Biomarker Reporting Committee, College of American Pathologists.

Arch Pathol Lab Med. 2016 Apr 15. [Epub ahead of print] No abstract available.

PMID:
27081879
22.

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.

Duncavage E, Advani RH, Agosti S, Foulis P, Gibson C, Kang L, Khoury JD, Medeiros LJ, Ohgami RS, O'Malley DP, Patel KP, Rosenbaum JN, Wilson C; Members of the Cancer Biomarker Reporting Committee, College of American Pathologists.

Arch Pathol Lab Med. 2016 Apr 15. [Epub ahead of print] No abstract available.

PMID:
27081876
23.

An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified.

Hoffmann JC, Chisholm KM, Cherry A, Chen J, Arber DA, Natkunam Y, Warnke RA, Ohgami RS.

Hum Pathol. 2016 Feb;48:9-17. doi: 10.1016/j.humpath.2015.09.033. Epub 2015 Oct 23.

PMID:
26772393
24.

Surface Light Chain Expression in Primary Mediastinal Large B-Cell Lymphomas by Multiparameter Flow Cytometry.

Weinberg OK, Rodig SJ, Pozdnyakova O, Ren L, Arber DA, Ohgami RS.

Am J Clin Pathol. 2015 Oct;144(4):635-41. doi: 10.1309/AJCP3Q1DHWKCQRWY.

PMID:
26386085
25.

Indolent T-lymphoblastic proliferation: a name with specific meaning.

Ohgami RS, Natkunam Y, Warnke RA.

Hum Pathol. 2015 Nov;46(11):1785-6. doi: 10.1016/j.humpath.2015.07.026. Epub 2015 Aug 11. No abstract available.

PMID:
26363525
26.

Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.

Johnson RC, Weinberg OK, Cascio MJ, Dahl GV, Mitton BA, Silverman LB, Cherry AM, Arber DA, Ohgami RS.

Am J Clin Pathol. 2015 Jul;144(1):103-12. doi: 10.1309/AJCPLUYF11HQBYRB.

PMID:
26071468
27.

The diagnostic and clinical impact of genetics and epigenetics in acute myeloid leukemia.

Ohgami RS, Arber DA.

Int J Lab Hematol. 2015 May;37 Suppl 1:122-32. doi: 10.1111/ijlh.12367. Review.

PMID:
25976970
28.

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, Miklos D, Advani RH, Levy R, Hicks RJ, Hertzberg M, Ohgami RS, Gandhi MK, Diehn M, Alizadeh AA.

Blood. 2015 Jun 11;125(24):3679-87. doi: 10.1182/blood-2015-03-635169. Epub 2015 Apr 17.

29.

Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.

Chisholm KM, Merker JD, Gotlib JR, Gitana G, Lefterova M, Zehnder JL, George TI, Arber DA, Ohgami RS.

Am J Clin Pathol. 2015 Apr;143(4):527-34. doi: 10.1309/AJCPZ3J4GEEYIRRA.

PMID:
25780004
30.

The utility of IgM, CD21, HGAL and LMO2 in the diagnosis of pediatric follicular lymphoma.

Karnik T, Ozawa MG, Lefterova M, Luna-Fineman S, Alvarez E, Link M, Zehnder JL, Arber DA, Ohgami RS.

Hum Pathol. 2015 Apr;46(4):629-33. doi: 10.1016/j.humpath.2014.12.016. Epub 2015 Jan 29.

PMID:
25701230
31.

Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.

Chalmers ZR, Ali SM, Ohgami RS, Campregher PV, Frampton GM, Yelensky R, Elvin JA, Palma NA, Erlich R, Vergilio JA, Chmielecki J, Ross JS, Stephens PJ, Hermann R, Miller VA, Miles CR.

Blood Cancer J. 2015 Feb 6;5:e278. doi: 10.1038/bcj.2014.95. No abstract available.

32.

Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.

Ohgami RS, Ma L, Merker JD, Gotlib JR, Schrijver I, Zehnder JL, Arber DA.

Mod Pathol. 2015 May;28(5):706-14. doi: 10.1038/modpathol.2014.160. Epub 2014 Nov 21.

33.

Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings.

Weinberg OK, Ohgami RS, Ma L, Seo K, Ren L, Gotlib JR, Seetharam M, Cherry A, Arber DA.

Am J Clin Pathol. 2014 Aug;142(2):190-5. doi: 10.1309/AJCPMLO84JDNVLNK.

PMID:
25015859
34.

Large B-cell lymphomas poor in B cells and rich in PD-1+ T cells can mimic T-cell lymphomas.

Ohgami RS, Zhao S, Natkunam Y.

Am J Clin Pathol. 2014 Aug;142(2):150-6. doi: 10.1309/AJCPFJWKQ6GTVQE6.

PMID:
25015854
35.

STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression.

Ohgami RS, Ma L, Monabati A, Zehnder JL, Arber DA.

Haematologica. 2014 Jul;99(7):e105-7. doi: 10.3324/haematol.2013.101543. Epub 2014 May 16. No abstract available.

36.

E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.

Ohgami RS, Chisholm KM, Ma L, Arber DA.

Am J Clin Pathol. 2014 May;141(5):656-64. doi: 10.1309/AJCP8M4QQTAZPGRP.

PMID:
24713736
37.

Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.

Ohgami RS, Sendamarai AK, Atwater SK, Liedtke M, Fleming MD, Natkunam Y, Warnke RA.

Am J Surg Pathol. 2014 Sep;38(9):1298-304. doi: 10.1097/PAS.0000000000000197.

PMID:
24618611
38.

Challenges in Consolidated Reporting of Hematopoietic Neoplasms.

Ohgami RS, Arber DA.

Surg Pathol Clin. 2013 Dec;6(4):795-806. doi: 10.1016/j.path.2013.08.001. Epub 2013 Oct 18.

PMID:
26839198
39.

Profound plasmacytosis in a patient with dengue.

Ewalt MD, Abeynayake J, Waggoner JJ, Pinsky BA, Ohgami RS.

Int J Hematol. 2013 Nov;98(5):518-9. doi: 10.1007/s12185-013-1452-3. Epub 2013 Oct 11. No abstract available.

PMID:
24114365
40.

Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.

Ohgami RS, Arber DA, Zehnder JL, Natkunam Y, Warnke RA.

Adv Anat Pathol. 2013 May;20(3):137-40. doi: 10.1097/PAP.0b013e31828d17ec. Review.

PMID:
23574769
41.

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.

Ohgami RS, Ma L, Merker JD, Martinez B, Zehnder JL, Arber DA.

Leukemia. 2013 Nov;27(11):2244-7. doi: 10.1038/leu.2013.104. Epub 2013 Apr 8. No abstract available.

PMID:
23563237
42.

TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.

Ohgami RS, Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA.

Am J Surg Pathol. 2012 Nov;36(11):1619-28. doi: 10.1097/PAS.0b013e318264e223.

PMID:
23060347
43.

DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups.

Ohgami RS, Ma L, Ren L, Weinberg OK, Seetharam M, Gotlib JR, Arber DA.

Br J Haematol. 2012 Oct;159(2):182-90. doi: 10.1111/bjh.12029. Epub 2012 Aug 28.

PMID:
22924777
44.

Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies.

Ohgami RS, Ohgami JK, Pereira IT, Gitana G, Zehnder JL, Arber DA.

Leukemia. 2011 Sep;25(9):1439-43. doi: 10.1038/leu.2011.107. Epub 2011 May 27.

PMID:
21617700
45.

The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.

Younes SF, Beck AH, Ohgami RS, Lossos IS, Levy R, Warnke RA, Natkunam Y.

Am J Clin Pathol. 2011 May;135(5):697-708. doi: 10.1309/AJCP7Z2BIBUNQPLZ.

46.

PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.

Sangoi AR, Ohgami RS, Pai RK, Beck AH, McKenney JK, Pai RK.

Mod Pathol. 2011 Mar;24(3):412-24. doi: 10.1038/modpathol.2010.176. Epub 2010 Oct 1.

47.

Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle.

Sendamarai AK, Ohgami RS, Fleming MD, Lawrence CM.

Proc Natl Acad Sci U S A. 2008 May 27;105(21):7410-5. doi: 10.1073/pnas.0801318105. Epub 2008 May 21.

48.

The Steap proteins are metalloreductases.

Ohgami RS, Campagna DR, McDonald A, Fleming MD.

Blood. 2006 Aug 15;108(4):1388-94. Epub 2006 Apr 11.

49.

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells.

Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, Fleming MD.

Nat Genet. 2005 Nov;37(11):1264-9. Epub 2005 Oct 16.

50.

nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse.

Ohgami RS, Campagna DR, Antiochos B, Wood EB, Sharp JJ, Barker JE, Fleming MD.

Blood. 2005 Nov 15;106(10):3625-31. Epub 2005 Jun 30.

Supplemental Content

Loading ...
Support Center